FDA Approves TRAMADOL HYDROCHLORIDE — Aurobindo Pharma Limited
Aurobindo Pharma Limited announced the approval of its ANDA (No. 203494) for Tramadol Hydrochloride tablets, heightening competition in the generic pain management market. The clearance of this ANDA is expected to broaden the generic pipeline's supply of the opioid analgesic, pressuring pricing dynamics in the established market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed